What were the results of the 4D and AURORA studies?
The results of the 4D study demonstrated that lowering LDL-C with atorvastatin in hemodialysis (HD) patients with type 2 diabetes did not produce statistically significant reductions in the primary outcome measure. The main results of AURORA were also negative.